Thank you for attending

TACOS Spring Membership Conference |
April 13, 2012

Doxil C.A.R.E.S. Physician Access Program Initiates Open Enrollment
FDA Approves Pazopanib Tablets for Soft Tissue Sarcoma
CMS Announces One-Year Delay in ICD-10 Compliance Deadline
New Route of Administration for Velcade
FDA Issues Advisory About Counterfeit Avastin
FDA Approves New Treatment for Basal Cell Carcinoma
FDA Warns of Risks of Unapproved Medications from Unlicensed Sources
New J-Codes/ C Code in 2012
Changes Made to Nplate PI
Send a Message to Congress: Fight Cancer, Not Cancer Care
New indications for Prolia (denosumab)
CMS Releases Information on Accessing 2010 PQRI and eRx Incentive Program Feedback Reports
FDA Approves Xalkori (crizotinib) for Patients with Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer

TACOS Advocacy

TACOS is raising its advocacy voice on state and federal issues.

Visit our state and federal advocacy pages to find out what we're doing to ensure that the voice of oncology in Arizona is heard.

TACOS values your input. Help us make a difference in our state. Do you know an Arizona State Legislature member? Do you have an issue you want to bring attention to? Please send all questions and comments to sabbott@accc-cancer.org.

Thank you for attending

TACOS Advocacy

TACOS is raising its advocacy voice on state and federal issues.

Get Connected: